Which then raises the question - why? Why would the US Dept Defence fund Penthrox. Maybe they can bypass the FDA but then again, I wonder how many hysterectomies and osteo related knee procedures are being done under US military medical coverage?
I suspect there is either some MVP money underpinning this research or the research is done for some universal benefit. If its the latter then its next to useless as we know that Penthrox does not sell without concerted efforts by a sales team.
All false hope I'm afraid.
Another Positive Study, page-168
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.69M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.5¢ | 44.5¢ | $26.82K | 59.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9869 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 38122 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |